Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lampl, Y.
Right arrow Articles by Gilad, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lampl, Y.
Right arrow Articles by Gilad, R.
Related Collections
Right arrow SPECT
Right arrow All Cognitive Disorders/Dementia
Right arrow Alzheimer's disease
Right arrowRelated Article
NEUROLOGY 2006;66:1253-1254
© 2006 American Academy of Neurology
Brief Communications

Annexin V SPECT imaging of phosphatidylserine expression in patients with dementia

Y. Lampl, MD*, M. Lorberboym, MD*, F. G. Blankenberg, MD, M. Sadeh, MD and R. Gilad, MD

From the Departments of Neurology (Y.L., M.S., R.G.) and Nuclear Medicine (M.L.), Edith Wolfson Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and Department of Radiology (F.G.B.), Stanford University Hospital, Stanford, CA.

Address correspondence and reprint requests to Dr. Mordechai Lorberboym, Department of Nuclear Medicine, Edith Wolfson Medical Center, Holon, 58100, Israel; e-mail: mvlorber{at}zahav.net.il

The authors sought to use radiolabeled annexin V, a marker of phosphatidylserine expression, to image Alzheimer dementia (AD). Four of five patients with AD had multifocal cortical annexin V uptake, whereas all seven non-AD and six control patients had normal SPECT. The mean cortex/cerebellar activity in patients with AD (1.4 ± 0.6) was higher than that of non-AD dementia patients (0.7 ± 0.2; p = 0.02). Radiolabeled annexin V may be useful for imaging AD.

*The first and second authors contributed equally to the manuscript.

Supported in part by Theseus Imaging Corporation, Cambridge, MA.

Disclosure: The authors report no conflicts of interest.

Received September 23, 2005. Accepted in final form January 18, 2006.


Related Article

April 25 Highlights
Neurology 2006 66: 1136-1137. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 J. Nucl. Med. Technol.Home page
T. E. Peterson and H. C. Manning
Molecular Imaging: 18F-FDG PET and a Whole Lot More
J. Nucl. Med. Technol., September 1, 2009; 37(3): 151 - 161.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
F. G. Blankenberg
In Vivo Detection of Apoptosis
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 81S - 95S.
[Abstract] [Full Text] [PDF]